Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2024-02-01 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulation 2015, we would like to inform you that the Company has received communication from its ....
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to stock exchanges regarding the loss of share certificates, referencing Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements). It provides details of the lost certificates and requests the information be taken on record. There is no financial data, report, or detailed analysis present. The document is an official notification related to share certificates but does not fit into categories like share issue, director dealings, or capital updates. Given its nature as a regulatory notification without substantive financial content, it best fits under Regulatory Filings (RNS). The document length is short (1590 characters), and it is not an announcement of a report but a direct regulatory communication.
2024-02-01 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the loss of share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, which pertains to reporting share certificate loss. The content is a notification about a specific event related to share certificates, not a financial report, management change, or other types of filings. It is a regulatory disclosure about share certificate loss, which fits best under Regulatory Filings (RNS) as it does not match any other specific category and is a compliance-related announcement.
2024-01-31 English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its ....
Regulatory Filings Classification · 100% confidence The document is a formal communication addressed to stock exchanges regarding the loss of share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, which pertains to share certificate loss and related disclosures. The content is a notification about a specific shareholder's lost share certificates and requests the exchanges to take the information on record. There is no financial data, no report attached or referenced, no management discussion, no earnings information, or any other report type content. This fits the category of a Regulatory Filing (RNS) as it is a compliance-related announcement that does not fit into other specific categories.
2024-01-31 English
Board Meeting — SANOFI INDIA LIMITED has informed the Exchange about Board Meeting to be held on 23-Feb-2024 to consider and approve the Yearly Audited Financial results of the Company for the period…
Regulatory Filings
2024-01-24 English
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document is a letter dated 24th January 2024 from Sanofi India Limited addressed to stock exchanges, informing about a scheduled Board of Directors meeting on 23rd February 2024. The letter states that the Board will consider approving audited financial statements for the quarter and financial year ended 31st December 2023 and recommend dividends. It also mentions the closure of the trading window for designated persons. The document is an announcement of a future board meeting and related compliance information, not the actual financial report or results. It does not contain financial data or detailed management discussion. Therefore, it is best classified as a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit other specific categories like Annual Report or Earnings Release.
2024-01-24 English
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/02/2024 ,inter alia, to consider and approve the Audited Financial Statements ....
Board/Management Information Classification · 95% confidence The document is a letter from the company secretary to stock exchanges informing about a forthcoming Board of Directors meeting scheduled for 23rd February 2024. The agenda includes approval of audited financial statements for the quarter and financial year ended 31st December 2023 and recommendation of dividend. It also mentions the closure of the trading window for insiders. The document is a notification about a board meeting and related compliance, not the actual financial report or results. It is short (2105 characters) and serves as an announcement rather than a report. Therefore, it fits best under Board/Management Information (MANG) as it relates to board meeting notification and regulatory compliance disclosures about board activities.
2024-01-24 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.